News

Drs. Holly Prigerson and Valerie Reyna have combined forces to study end-of-life communication between patients and their physicians and clinicians, with the goal of improved prognostic understanding and decision-making and, ultimately, better end-of-life decisions. They have received a Cornell intercampus seed grant that has sparked additional collaborations and new NIH-funded studies.

The protein adipsin, which is produced in body fat, helps protect insulin-secreting cells called pancreatic beta cells from destruction in type 2 diabetes, according to a new study by researchers at Weill Cornell Medicine and NewYork-Presbyterian. 

In recognition of its outstanding continued commitment to diversity and inclusion, Weill Cornell Medicine has been awarded the Health Professions Higher Education Excellence in Diversity (HEED) Award by INSIGHT Into Diversity magazine for the second year in a row.

A protein that breast, lung and other cancers use to promote their spread—or metastasis—to the brain, has been identified by a team led by Weill Cornell Medicine and New York-Presbyterian investigators. The protein, CEMIP, will now be a focus of efforts to predict, prevent and treat brain metastases, which are a frequent cause of cancer deaths.

Awards, honors, prizes and achievements for the month of October.

For patients with a genetic syndrome that predisposes them to many cancers, a new vaccine could be a lifesaver

Personalized medical interventions to improve cardiovascular, metabolic and other modifiable risk factors for Alzheimer’s disease may improve cognitive function, according to a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian. 

Dr. Randy Longman, an accomplished physician-scientist, has been appointed director of the Jill Roberts Center for Inflammatory Bowel Disease at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.

Dr. Nicole Serlé Henwood is fighting to find a cure for her son’s rare disease.

A high-salt diet may negatively affect cognitive function by causing a deficiency of the compound nitric oxide, which is vital for maintaining vascular health in the brain, according to a new study in mice from Weill Cornell Medicine researchers. 

New cellular and molecular processes underlying communication between gut microbes and brain cells have been described for the first time by scientists at Weill Cornell Medicine and Cornell’s Ithaca campus.

A set of powerful laboratory and computational techniques developed by scientists at Weill Cornell Medicine, the New York Genome Center (NYGC) and the Broad Institute will enable investigators to map the capacity of tumors to develop resistance to drugs and drug combinations. 

Dr. Rainu Kaushal, chair of the Department of Healthcare Policy and Research at Weill Cornell Medicine and physician-in-chief of healthcare policy and research at NewYork-Presbyterian/Weill Cornell Medical Center, and Dr. Deborah Estrin, a professor of healthcare policy and research at Weill Cornell Medicine and associate dean for impact at Cornell Tech, have been elected to the National Academy of Medicine (NAM).

In the roughly 100 years since Alois Alzheimer first described the devastating neurodegenerative disease that now bears his name, scientists have developed an increasingly sophisticated understanding of the brain. 

More than 80 Weill Cornell Medicine students, faculty and senior leadership gathered Oct. 7 at Weill Cornell Medicine for a ribbon-cutting ceremony for the Feil Family Student Center, which occupies renovated first and second floors in the main campus buildings on York Avenue. The state-of-the-art center was made possible by a $12.5 million gift from the Feil Family.

Dr. Hagen Tilgner is exploring how faulty building instructions for brain cells may give rise to depression, schizophrenia, Alzheimer’s disease and more

Dr. Samie R. Jaffrey, the Greenberg-Starr Professor of Pharmacology at Weill Cornell Medicine, has been awarded a Maximizing Investigators’ Research Award (MIRA) from the National Institute of Neurological Disorders and Stroke (NINDS).

Weill Cornell Medicine scientists have built the first 3-D-printed automated synthesis units (ASUs) for producing customized radioactive drugs.

Researchers in Doha and New York are collaborating to explore the Qatari genome.

Dr. Peter Goldstein, a professor of anesthesiology at Weill Cornell Medicine, has been awarded a grant from the National Institutes of Health  for a project to develop a non-opioid, non-addicting medicine for a hard-to-treat form of pain called neuropathic pain.